MarketWatch  Aug 13  Comment 
Pharmacy-benefit managers may drive hard bargains with drug manufacturers, but they keep finding ways to boost their bottom line at the expense of employers and patients.
Yahoo  Jul 31  Comment 
"I believe the administration does want to remove rebates, and they consider it a priority," he said in an interview, following similar comments made on Pfizer's conference call to discuss second quarter earnings. The administration has already...
GenEng News  Jul 17  Comment 
One of the biopharma industry’s two key trade groups yesterday called for replacing the current system that allows drug manufacturers to offer rebates in return for their medicines being given preference on the formularies of pharmaceutical...
Insurance Journal  Mar 16  Comment 
A tribe in Oklahoma has filed a lawsuit accusing 26 drug manufacturers and distributors of contributing to the tribe’s opioid epidemic by fraudulently misrepresenting the risks and benefits of addictive painkillers. The lawsuit filed by the...
Wall Street Journal  Mar 15  Comment 
Health-care payer consolidation continues at a rapid pace. Look for drug manufacturers to chime in with some larger deals of their own.
Forbes  Mar 6  Comment 
UnitedHealth Group will pass along pharmacy discounts it gets from drug manufacturers from rebates via a new program for its full-insured customers at the point of prescription sale.
The Economic Times  Feb 20  Comment 
NPPA's study found that "the major beneficiaries of profits in all these cases because of inflated MRPs have been hospitals rather than drug manufacturers”.
GenEng News  Jan 4  Comment 
Actively targeting specific genetic mutations that give rise to cancer is challenging enough for researchers and drug manufacturers, but trying to target changes that arise due to differential expression and regulation of gene products takes the...
GenEng News  Dec 20  Comment 
Side effects from chemotherapy can range from the mildly acute, such as nausea, to severe chronic disorders, like hearing loss. Understanding and potentially mitigating side effects are of paramount concern for clinicians, drug manufacturers, and...
MedPage Today  Dec 14  Comment 
(MedPage Today) -- Some blame PBMs, others fault drug manufacturers

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki